ArticleFrontiers in oncology2021

Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Yuhui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.